Latest Shareholder Approvals News

Core Energy Minerals has appointed Anthony Greenaway as Managing Director, aiming to leverage his extensive exploration expertise to advance its uranium and rare earth projects in South Australia and Brazil.

Peel Mining has appointed a new leadership team with deep mining and capital markets expertise, aiming to unlock significant value from its copper and polymetallic assets in the prolific Cobar region. The company signals a strategic shift towards targeted exploration, regional consolidation, and disciplined growth.

Activeport Group Ltd has successfully raised $6.68 million through a two-tranche placement, positioning the company to accelerate its software development and target cash flow positivity in FY26.

Altitude Minerals has successfully raised $2.5 million to advance exploration at its promising silver and gold projects in Nevada and copper-gold targets in New South Wales, aiming to sustain momentum through 2026.

Lunnon Metals has formalized an Ore Purchase Agreement with Gold Fields subsidiary St Ives Gold Mining, setting the stage for development of the high-grade Lady Herial gold deposit. The agreement outlines a 70, 30 free cash flow split and awaits shareholder and regulatory approvals.

Platinum Asset Management confirms the Independent Expert's valuation of its proposed merger with L1 Capital remains unchanged after reviewing updated financials, with the Board unanimously recommending shareholder approval.

My Foodie Box Limited has raised $500,000 through unsecured promissory notes to support its transformation into Tarrina Resources and relisting on the ASX as a resource exploration company.

Leo Lithium has announced a significant $330 million return to shareholders in 2025, following the termination of its asset acquisition strategy and a decision to monetise remaining assets.

Resolution Minerals Ltd has successfully raised $25.1 million through a heavily supported placement, positioning itself to advance its Horse Heaven Project in Idaho and prepare for a NASDAQ listing.

Midas Minerals has raised $11.5 million through a strongly supported placement to fund its acquisition and exploration efforts at the Otavi Copper Project in Namibia.

Neurizon Therapeutics has raised $5 million through an institutional placement to advance its lead ALS drug candidate NUZ-001 into a pivotal clinical trial, pending FDA clearance. The capital injection also supports manufacturing and pre-clinical development efforts.

Mont Royal Resources Ltd (ASX – MRZ) has lodged a prospectus to raise between A$8 million and A$10 million through a share offer priced at A$0.20 each, coinciding with a proposed merger with Commerce Resources Corp (TSXV – CCE). The combined entity aims to become a leading Quebec-focused critical minerals developer.